Dr. Adrienne Wright is a leading expert in veterinary regenerative medicine, with over a decade of experience in stem cell therapy, platelet-rich plasma (PRP), and biologics. She currently serves as the Vice President of Science and Commercialization and Site Leader of Ardent Animal Health, where she oversees scientific research, regulatory strategy, and product development across the regenerative portfolio.
Adrienne holds a PhD in Anatomy & Physiology from Kansas State University’s College of Veterinary Medicine, where her research focused on development of the protocol for isolation of canine MSCs from Wharton’s jelly and extracellular vesicles derived from both human and canine MSCs. She also earned an MBA in Data Analytics, adding strategic and analytical depth to her scientific leadership.
With a background spanning both academic research and biopharmaceutical industry roles, Adrienne brings a uniquely integrated perspective to clinical translation. She has authored multiple peer-reviewed publications and a U.S. provisional patent on the isolation, cell culture, and cryopreservation of canine WJ-MSCs. In her current role, she collaborates closely with veterinarians, researchers, and regulators to advance regenerative solutions that improve animal health.
Dr. Wright is passionate about education and innovation in veterinary medicine, and she regularly shares her expertise through continuing education programs, clinical collaborations, and industry partnerships. Adrienne lives in Lexington with her husband, Jacob, her children, Benjamin and Eleanor, and her dog, Blanche.